Abstract: Antibody formulations are described comprising a mixture of a non-reducing sugar, an anti-?4?7 antibody and at least one amino acid. The disclosed formulations have improved stability, reduced aggregate formation, and may retard degradation of the anti-?4?7 antibody therein or exhibit any combinations thereof. The present invention further provides a safe dosing regimen of these antibody formulations that is easy to follow, and which results in a therapeutically effective amount of the anti-?4?7 antibody in vivo.

Abstract: A facility for generating an advertising message is described. The facility extracts visual content from a model web page. The facility then constructs an advertising message that contains the extracted visual content.

Abstract: Antibody formulations are described comprising a mixture of an anti-?4?7 antibody, an antioxidant or chelator, and at least one free amino acid. The disclosed formulations may have improved stability, reduced aggregate formation, or both. The present invention further provides a safe dosing regimen of these antibody formulations that is easy to follow, and which results in a therapeutically effective amount of the anti-?4?7 antibody in vivo.

Abstract: A facility for constructing an advertising message in connection with a web page is described. The facility obtains text associated with the web page, and uses the obtained text to generate a query. The facility uses the generated query to select a stock photography image, and generates an advertising message that incorporates the selected stock photography image.

Abstract: A facility for constructing an advertising message in connection with a web page is described. The facility obtains text associated with the web page, and uses the obtained text to generate a query. The facility uses the generated query to select a stock photography image, and generates an advertising message that incorporates the selected stock photography image.

Abstract: A security frame is disclosed that is adapted to be fitted to door and window openings and adjustably accommodate decorative panels of differing thicknesses. The frame includes: at least two frame members connectable together to form the frame for accommodating at least one decorative panel; at least one panel clamping bed extending along an inner sidewall of each frame member and having a clamping portion and a channel; and at least one clamping clip including at least one clamping arm configured to clamp a peripheral edge of the at least one decorative panel against the clamping portion. The at least one clamping clip and the channel connect via key arrangements configured to intermesh at a plurality of positions thereby enabling decorative panels of differing thicknesses to be accommodated and clamped to the frame.

Abstract: A composition comprising: a plurality of identical first synthetic nucleotide oligomers; and a plurality of identical second synthetic nucleotide oligomers which are different to the first synthetic nucleotide oligomers, wherein each of the first synthetic nucleotide oligomers comprises a first primer binding sequence of bases, a first identifier sequence of three to seven bases in length, and a second primer binding sequence of bases, the first identifier sequence being disposed between the first and second primer binding sequences, wherein each of the second synthetic nucleotide oligomers comprises a third primer binding sequence of bases, a second identifier sequence of three to seven bases in length, and a fourth primer binding sequence of bases, the second identifier sequence being disposed between the third and fourth primer binding sequences, and wherein the first identifier sequence is different to the second identifier sequence.

Abstract: One or more techniques and/or systems are provided for evaluating dispenser functionality of a dispenser for dispensing a material. In an example, a non-loaded electrical characteristic and/or a loaded electrical characteristic of the dispenser may be measured and evaluated to determine whether to perform a dispense event. In another example, current measurements, such as peak current, may be measured during a dispense event. The current measurements may be evaluated to determine whether a problem exists, such as a mechanical stall, a gear train problem, an actuator problem, a pump problem (e.g., a clogged pump), a mechanical impedance, and/or other issue. Such information may be collected, stored as historical data, and/or used to determine whether to perform subsequent dispense events.

Abstract: A coating composition consisting essentially of one or more aliphatic or aromatic polyisocyanates, or combinations thereof, one or more catalysts, and one or more solvents. The composition is capable of forming a hard clear protective paint coating when applied to a surface, and the polyisocyanate is allowed to react with ambient moisture. A method for applying the coating comprising filtering compressed air to reduce moisture and impurities and then applying the coating composition to a painted surface using the filtered compressed air.

Abstract: Antibody formulations are described comprising a mixture of a non-reducing sugar, an anti-?4?7 antibody and at least one amino acid. The disclosed formulations have improved stability, reduced aggregate formation, and may retard degradation of the anti-?4?7 antibody therein or exhibit any combinations thereof. The present invention further provides a safe dosing regimen of these antibody formulations that is easy to follow, and which results in a therapeutically effective amount of the anti-?4?7 antibody in vivo.

Abstract: The present invention relates to a security frame adapted to be fitted to door and window openings and adjustably accommodate decorative panels of differing thicknesses.

Abstract: Antibody formulations are described comprising a mixture of a non-reducing sugar, an anti-?4?7 antibody and at least one amino acid. The disclosed formulations have improved stability, reduced aggregate formation, and may retard degradation of the anti-?4?7 antibody therein or exhibit any combinations thereof The prese invention further provides a safe dosing r men of these antibody formulations that is easy to follow, and which results in a therapeutically effective amount of the anti-?4?7 antibody in vivo.

Abstract: A new and distinct variety of landscape shrub rose plant herein referred to by its cultivar name, ‘Radgardebwhite’, is provided which forms in abundance on a substantially continuous basis attractive, double white colored blossoms. The vegetation is vigorous and the growth habit is very bushy and rounded. Attractive, semi-glossy, medium green foliage is formed. Excellent disease resistance is exhibited. Additionally, the new variety is particularly well suited for growing as distinctive ornamentation in the landscape.

Abstract: Antibody formulations are described comprising a mixture of an anti-a4b7 antibody, an antioxidant or chelator, and at least one free amino acid. The disclosed formulations may have improved stability, reduced aggregate formation, or both. The present invention further provides a safe dosing regimen of these antibody formulations that is easy to follow, and which results in a therapeutically effective amount of the anti-a4b7 antibody in vivo.

Abstract: A system includes a processor configured to receive a user request to edit vehicle feature settings from a computer remote from a vehicle. The processor is also configured to retrieve saved vehicle feature setting configurations associated with a vehicle associated with an identified user account. The processor is further configured to build a current feature setting configuration display. Also, the processor is configured to present a user-configurable version of the display on a user interface. The processor is additionally configured to receive changes to current features setting configurations. The processor is also configured to save the changes and upload the changes to the vehicle.

Abstract: Antibody formulations are described comprising a mixture of an anti-?4?7 antibody, an antioxidant or chelator, and at least one free amino acid. The disclosed formulations may have improved stability, reduced aggregate formation, or both. The present invention further provides a safe dosing regimen of these antibody formulations that is easy to follow, and which results in a therapeutically effective amount of the anti-?4?7 antibody in vivo.

Abstract: Antibody formulations are described comprising a mixture of an anti-?4?7 antibody, an antioxidant or chelator, and at least one free amino acid. The disclosed formulations may have improved stability, reduced aggregate formation, or both. The present invention further provides a safe dosing regimen of these antibody formulations that is easy to follow, and which results in a therapeutically effective amount of the anti-?4?7 antibody in vivo.

Abstract: A system and method of for describing target data as a sequence of pattern elements and pattern element groups that comprise an overall target pattern is described. Pattern elements may utilize regular expression syntax along with other metadata that describe the behavior of the element. A pattern element group may be a collection of fully defined pattern elements where at least one pattern element from the group must have a match for the overall pattern to match. Patterns contain both pattern elements and pattern element groups. The general process involves first performing optical character recognition (OCR) on the document, which in turn produces a sequence of text tokens representing the lines of text on each page of the document. The search algorithm may then apply each defined pattern to the entire document capturing and/or extracting data that match each pattern's required elements and element groups.

Abstract: Antibody formulations are described comprising a mixture of a non-reducing sugar, an anti-?4?7 antibody and at least one amino acid. The disclosed formulations have improved stability, reduced aggregate formation, and may retard degradation of the anti-?4?7 antibody therein or exhibit any combinations thereof. The present invention further provides a safe dosing regimen of these antibody formulations that is easy to follow, and which results in a therapeutically effective amount of the anti-?4?7 antibody in vivo.

Abstract: A new and distinct variety of landscape shrub rose plant herein referred to by its cultivar name, ‘Radgardebwhite’, is provided which forms in abundance on a substantially continuous basis attractive, double white colored blossoms. The vegetation is vigorous and the growth habit is very bushy and rounded. Attractive, semi-glossy, medium green foliage is formed. Excellent disease resistance is exhibited. Additionally, the new variety is particularly well suited for growing as distinctive ornamentation in the landscape.